• Maps & Facts
  • Who We Are
  • Pipeline
  • Newsroom
  • Leadership
  • Takeda Careers
  • Terms of Use
  • Privacy Policy

  • Follow us

 

TAKEDA VACCINE BUSINESS 
PRESS RELEASES

January 29, 2018

Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation

Read the full story
November 28, 2017

Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate

Read the full story
November 07, 2017

Takeda’s Dengue Vaccine Candidate Associated with Reduced Incidence of Dengue in Children and Adolescents; New 18-Month Interim Phase 2 Data Published in The Lancet Infectious Diseases

Read the full story
June 26, 2017

Takeda and Biological E. Limited Announce Partnership to Develop Low-Cost Combination Vaccines for Low- and Middle-Income Countries around the Globe

Read the full story
May 09, 2017

Takeda Terminates Plans for VAXEM Hib® Launch in Japan Due to the Vaccine Supplier’s (GSK) Decision to Discontinue Global Production

Read the full story
April 05, 2017

Takeda Completes Enrollment of More Than 20,000 Children and Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate

Read the full story
March 29, 2017

Takeda’s Dengue Vaccine Candidate Elicited Broad Immune Responses in Children and Adolescents Living in Dengue-Endemic Areas; Interim Phase 2 Analysis Published in The Lancet Infectious Diseases

Read the full story
November 30, 2016

Takeda to invest more than 100 Million Euros in Dengue Vaccine Manufacturing plant in Germany

Read the full story
September 21, 2016

Takeda and Zydus Cadila partner to address the global threat of Chikungunya

Read the full story
September 07, 2016

Takeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccine Candidate (TAK-003)

Read the full story
LOAD MORE

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies. If you want more information about cookies, the types we use, and how to control them, please see Takeda's Cookie Policy page.

Close OK

YOU ARE ABOUT TO LEAVE THIS WEBSITE AND ENTER A WEBSITE OPERATED BY AN INDEPENDENT THIRD PARTY

The links to third-party websites contained on this website are provided solely for your convenience. Takeda does not control the content contained on any third-party website linked from this website. Your activities on those websites will be governed by the policies and practices of those third parties.

Please select "Continue" if you wish to be taken to this third-party website.